Prostate cancer kills twice as many Black men as white men in the U.S. Beyoncé's father has signed onto a new $20 million ...

Novartis has committed $7.5 million to an initiative aiming to save 100,000 lives by 2035. The money will launch Zero ...

The PORTOS assay could indicate when or when not to offer dose-escalated radiation for localized prostate cancer.

(UroToday.com) The 2025 American Society of Clinical Oncology Genitourinary (ASCO GU) cancers symposium held in San Francisco, CA was host to the Poster Session A: Prostate Cancer. Dr. Moein Moradpour ...

Barry Goy, MD, provides insight into the clinical implications of a retrospective analysis examining 15-year outcomes in patients with intermediate-risk prostate cancer.

Quality of life, treatment impact and duration, and the importance of individualized therapy are at the center of ...

PORTOS can determine which patients with localized prostate cancer will benefit from dose-escalation of radiotherapy, data suggest.

After an apparent accidental early release, Pfizer has revealed phase 1 data showing its investigational candidate, alongside ...

When prostate cancer metastasizes, spreads outside of the prostate itself, it typically affects the structures in its immediate vicinity. Structures near the prostate likely to be involved include ...

Dimitrios Kambouris/Getty Images for Blue Jacket Fashion Show Proceeds from the show went to the nonprofit foundation, ZERO Prostate Cancer, which will "support the prostate community, improve ...